Patient-Derived Xenografts

Chapter 1 Patient-Derived Xenografts: Historical Evolution, Immunocompromised Host Models, and Translational Significance

Chapter 2 Patient-Derived Xenograft Models in Cancer Research: Methodology, Applications, and Future Prospects

Chapter 3 Patient-Derived Xenografts: A Valuable Preclinical Model for Drug Development and Biomarker Discovery

Chapter 4 Patient-Derived Xenograft Models for Leukemias

Chapter 5 Patient-Derived Orthotopic Xenograft Models for High-Grade Pediatric Brain Cancers

Chapter 6 Generation of Orthotopic and Subcutaneous Patient-Derived Xenograft Models from Diverse Clinical Tissue Samples of Pediatric Extracranial Solid Tumors

Chapter 7 Development of Orthotopic Patient-Derived Xenograft Models of Pediatric Intracranial Tumors

Chapter 8 A Humanized Patient-Derived Xenograft Model for Pancreatic Cancer

Chapter 9 Development and Expansion of Patient-Derived Xenografts for Endometrial Cancer

Chapter 10 A Multiplexed Approach to Assess Small Cell Lung Cancer Subtype Heterogeneity in Primary and Patient-Derived Tumor Samples

Chapter 11 Generation of Metastatic Cholangiocarcinoma Patient-Derived Xenograft Models

Chapter 12 Patient-Derived Xenograft Models for Translational Prostate Cancer Research and Drug Development

Chapter 13 Patient-Derived Xenograft Models for Ovarian Cancer

Chapter 14 Orthotopic MC-38 Allograft as a Robust Preclinical Model of Colorectal Carcinoma

Chapter 15 Assessing Protein Expression in Patient-Derived Xenografts Using Western Blotting

Chapter 17 A Semiautomated Proteomics and Phosphoproteomics Protocol for the Identification of Novel Therapeutic Targets and Predictive Biomarkers in In Vivo Xenograft Models of Pediatric Cancers